Conducting meaningful research is an important part of our mission for integrative health. Having participants in our studies is vital to the success of our clinical research.
Below are the studies that are currently recruiting participants. If you are interested, please reach out directly to the contact staff in each study. For any questions, please contact us at ssihi@hs.uci.edu. You can find more UCI Health clinical trials here.
Current Clinical Trials
Electroacupuncture in the Treatment of Hypertension Research Study
Lead Researcher: Shaista Malik, MD, PhD, MPH
Location: UCI Health
Overview
We are recruiting participants for a research study to determine the effectiveness of electroacupuncture (EA therapy) in decreasing blood pressure in those who are diagnosed with high blood pressure and not on medication, as well as those already on medication.
You may eligible to participate in this study if:
- You are 18 years of age or older
- You have been clinical diagnosed with high blood pressure without cardiac diseases
- Your blood pressure is not greater than 160/100 mmHg
- You will be required to use a 24-hour BP monitoring device (given to you by the studyteam) to confirm your eligibility.
- You are not pregnant or nursing an infant
Study Visits
Minimum of 12 visits over three months for those NOT on medication and 24-33 visits over a period of 33 weeks for those ON medication. Each visit will be about 1 hour long and will include a 30-minute electroacupuncture (EA) therapy session. Participants will be randomized to different treatment protocols, including sham electroacupuncture.
Compensation: Earn up to $100
Parking: Free upon validation
To learn more about this study and to inquire if you are eligible, please contact:
Email: acupuncturestudy@hs.uci.edu
Ashwini Erande, MS, MPH: 714-456-7025
Marcy Martinez: 424-394-0820
UCI IRB # 19992222 | Renewal / Amendment | Approved: 06-20-2024
Estudio de Investigación sobre la Electroacupuntura en el Tratamiento de la Hipertensión
Investigadora principal: Shaista Malik, MD, PhD, MPH
Ubicación: UCI Health
Overview
Condición/Enfermedad: Hipertensión
Propósito: Determinar la eficacia de la electroacupuntura para disminuir la presión arterial en aquellos a quienes se les acaba de diagnosticar hipertensión y que no toman medicamentos, así como en aquellos que ya los toman. El estudio incluye sesiones de terapia de electroacupuntura (EA) de 30 minutos una o dos veces por semana. Los participantes que toman medicamentos serán asignados aleatoriamente a una secuencia de dos tratamientos de EA diferentes y los que NO toman medicamentos serán asignados a una de cada 4 terapias de EA.
English version: versión en inglés
Participate
Elegibilidad
- Edad de 18 años o más
- Mujeres y hombres con diagnóstico clínico de hipertensión sin enfermedades cardíacas. Su presión arterial no es superior a 170/110 mmHg
Para mujeres
No está embarazada ni amamantando a un bebé.
Compromiso de tiempo
este es un estudio a corto plazo que requiere 12 visitas para aquellos que NO toman medicamentos y entre 24 y 33 visitas de estudio (dependiendo de su respuesta a la terapia con EA) durante un período de 33 semanas para los participantes que toman medicamentos.
Beneficios
Es posible que no reciba ningún beneficio directo por participar en este estudio. los investigadores esperan que la electroacupuntura pueda disminuir la presión arterial y ser eficaz con menos efectos secundarios que el tratamiento estándar (habitual), todavía no hay pruebas de ello. Si está en el grupo que recibe la terapia EA, puede beneficiarse de participar en el estudio.
Compensación
Tarjeta de regalo de $100 por curso de tratamiento de 8 semanas al finalizar cada tratamiento de EA.
Tratamiento:
Terapia de electroacupuntura
Contact Us
Marcy Martinez: Teléfono 424-394-0820 | Correo electrónico marcyem@hs.uci.edu
UCI IRB Approved: 05-12-2021 | MOD# 29331 | HS# 1999-2222
About the study:
Prediabetes is a widespread health condition that affects more than 1 in 3 Americans. As you may know, about 1 in 2 Asian American adults have diabetes or prediabetes. However, Asian Americans have been understudied in diabetes and prediabetes research.
Prediabetes is a health condition in which your blood sugar levels are higher than normal, but not high enough yet to be diagnosed as type 2 diabetes. Prediabetes can lead to heart disease, stroke, and type 2 diabetes. Fortunately, prediabetes can often be reversed with lifestyle changes.
Our research team is testing the effects of the Fasting Mimicking Diet (FMD), also known as Prolon®, on Asian Americans with prediabetes. FMD has been proven to have metabolic benefits in those with type 2 diabetes, but has yet to be tested on Asian Americans with prediabetes. Through this pilot study, we will test the feasibility and preliminary health effects of FMD on Asian Americans. We are looking for volunteers to participate in a 5-day FMD study in which all your meals for five days are provided ($185 value). Participants will meet with our research team before and after completion of the FMD program to complete health-related surveys, body measurements, blood pressure, and blood glucose and ketone assessment.
We are looking for participants who:
- Identify as Asian/Asian American
- Are age 30-65
- Are currently diagnosed with prediabetes (fasting blood glucose 100-125 mg/dl, HbA1c 5.7-6.4%, OR oral glucose tolerance test [OGTT] 140-199 mg/dl)
- Have not completed a 5-day FMD in the past year
- Are not pregnant or nursing
- Do not have nut or seed allergies
If you fit this criteria and are interested in participating, please fill out this 3-minute survey and a member of our team will follow up with you.
Participation not only provides an opportunity to learn more about diabetes and strategies for lowering the risk of diabetes through a healthy lifestyle, but also helps advance our mission towards healthier Asian American communities.
For more information, please email the study team at prediabetesstudy@uci.edu. Feel free to share with family or friends who might also be interested!
Study investigators:
Hannah Lui Park, PhD
Associate Professor In Residence, Pathology & Laboratory Medicine
School of Medicine
Associate Professor In Residence, Epidemiology & Biostatistics
Joe C. Wen School of Population & Public Health
UC Irvine
Karen Lindsay, PhD, RDN
Assistant Professor, Pediatrics
School of Medicine
Assistant Professor, Population Health & Disease Prevention
Joe C. Wen School of Population & Public Health
Registered Dietician Nutritionist
Susan Samueli Integrative Health Institute
UC Irvine
Nathan Wong, PhD, MPH
Professor, Medicine
Director, UCI Heart Disease Prevention Program (Preventive Cardiology)
School of Medicine
Professor, Epidemiology & Biostatistics and Population Health & Disease Prevention
Joe C. Wen School of Population & Public Health
UC Irvine
This study is funded by the UCI Susan Samueli Integrative Health Institute.
UCI IRB HS2023-4223 ⎹ Approved 7/26/2024
